{ "cik": 1453687, "cik_padded": "0001453687", "entityName": "Cartesian Therapeutics, Inc.", "fiscal_years": [ { "accn": "0001453687-26-000064", "filed": "2026-03-09", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 5454000.0, "cash": 125139000.0, "eps_diluted": -5.02, "free_cash_flow": -79395000.0, "net_income": -130302000.0, "operating_cash_flow": -73941000.0, "operating_income": -143405000.0, "revenue": 2797000.0, "stockholders_equity": -126240000.0, "total_assets": 296411000.0, "total_liabilities": 422651000.0 }, "period_end": "2025-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": -0.9281217073985557, "roa_avg2y": -0.35629188689615193, "roa_period_end": -0.439599070209945, "roe_avg2y": 1.9588099998496715 } }, { "accn": "0001453687-26-000064", "filed": "2026-03-09", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 9093000.0, "cash": 212610000.0, "eps_diluted": -4.49, "free_cash_flow": -32767000.0, "net_income": -77424000.0, "operating_cash_flow": -23674000.0, "operating_income": -43897000.0, "revenue": 38913000.0, "stockholders_equity": -6802000.0, "total_assets": 435023000.0, "total_liabilities": 441825000.0 }, "period_end": "2024-12-31", "ratio_units": { "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "operating_margin": -1.1280805900341788, "revenue_growth_yoy": 0.49642362713428706, "roa_avg2y": -0.20923341346056404, "roa_period_end": -0.17797679662914376, "roe_avg2y": 0.3464269574438573 } }, { "accn": "0001453687-26-000064", "filed": "2026-03-09", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 206000.0, "cash": 76911000.0, "eps_diluted": -49.76, "free_cash_flow": -51367000.0, "net_income": -219710000.0, "operating_cash_flow": -51161000.0, "operating_income": -86416000.0, "revenue": 26004000.0, "stockholders_equity": -440184000.0, "total_assets": 305050000.0, "total_liabilities": 444680000.0 }, "period_end": "2023-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -0.933077955390966, "roa_period_end": -0.7202425831830849, "roe_avg2y": 1.2686946378870296 } }, { "accn": "0001453687-25-000060", "filed": "2025-03-13", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1201000.0, "cash": 106438000.0, "eps_diluted": 0.1, "free_cash_flow": -32832000.0, "net_income": 35379000.0, "operating_cash_flow": -31631000.0, "operating_income": 14538000.0, "stockholders_equity": 93828000.0, "total_assets": 165886000.0, "total_liabilities": 72058000.0 }, "period_end": "2022-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": 0.21720298739290725, "roa_period_end": 0.21327297059426353, "roe_avg2y": 0.6081530567516695 } }, { "accn": "0001453687-24-000036", "filed": "2024-03-07", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1085000.0, "cash": 114057000.0, "eps_diluted": -0.22, "free_cash_flow": -61467000.0, "net_income": -25687000.0, "operating_cash_flow": -60382000.0, "operating_income": -4597000.0, "stockholders_equity": 22521000.0, "total_assets": 159883000.0, "total_liabilities": 137362000.0 }, "period_end": "2021-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -0.15791932816505697, "roa_period_end": -0.16066123352701664, "roe_avg2y": -11.378516057585825 } }, { "accn": "0001453687-24-000036", "filed": "2024-03-07", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 815000.0, "cash": 138685000.0, "eps_diluted": -0.68, "free_cash_flow": 34066000.0, "net_income": -68876000.0, "operating_cash_flow": 34881000.0, "operating_income": -56821000.0, "stockholders_equity": -18006000.0, "total_assets": 165435000.0, "total_liabilities": 183441000.0 }, "period_end": "2020-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -0.5198110217204268, "roa_period_end": -0.41633269864297157, "roe_avg2y": 14.335726922676658 } }, { "accn": "0001453687-23-000040", "filed": "2023-03-02", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 47000.0, "cash": 89893000.0, "eps_diluted": -1.22, "free_cash_flow": -51482000.0, "net_income": -55350000.0, "operating_cash_flow": -51435000.0, "operating_income": -52455000.0, "stockholders_equity": 8397000.0, "total_assets": 99569000.0, "total_liabilities": 91172000.0 }, "period_end": "2019-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -0.7684778307682696, "roa_period_end": -0.5558959113780394, "roe_avg2y": -37.16012084592145 } }, { "accn": "0001453687-22-000051", "filed": "2022-03-10", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 884000.0, "cash": 37403000.0, "free_cash_flow": -60045000.0, "net_income": -65336000.0, "operating_cash_flow": -59161000.0, "operating_income": -65022000.0, "stockholders_equity": -5418000.0, "total_assets": 44482000.0, "total_liabilities": 49900000.0 }, "period_end": "2018-12-31", "ratio_units": { "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_period_end": -1.468818848073378, "roe_avg2y": -2.816449693939133 } }, { "accn": "0001453687-21-000031", "filed": "2021-03-12", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD" }, "fundamentals": { "capex": 733000.0, "cash": 70622000.0, "free_cash_flow": -52759000.0, "net_income": -65321000.0, "operating_cash_flow": -52026000.0, "operating_income": -63784000.0, "stockholders_equity": 51814000.0 }, "period_end": "2017-12-31", "ratio_units": { "roe_avg2y": "ratio" }, "ratios": { "roe_avg2y": -1.2235719436925756 } }, { "accn": "0001453687-20-000028", "filed": "2020-03-12", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "net_income": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 586000.0, "cash": 58656000.0, "net_income": -36210000.0, "operating_income": -34670000.0, "revenue": 8083000.0, "stockholders_equity": 54957000.0, "total_assets": 89301000.0, "total_liabilities": 34344000.0 }, "period_end": "2016-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio" }, "ratios": { "revenue_growth_yoy": 0.34470138080186324, "roa_avg2y": -0.5481173131504258, "roa_period_end": -0.4054825813820674 } }, { "accn": "0001453687-17-000014", "filed": "2017-03-28", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "revenue": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "revenue": 6011000.0, "total_assets": 42824000.0, "total_liabilities": 21835000.0 }, "period_end": "2015-12-31", "ratio_units": { "revenue_growth_yoy": "ratio" }, "ratios": { "revenue_growth_yoy": 0.9773026315789474 } }, { "accn": "0001453687-17-000014", "filed": "2017-03-28", "fiscal_year": 2014, "form": "10-K", "fundamental_units": { "revenue": "USD" }, "fundamentals": { "revenue": 3040000.0 }, "period_end": "2014-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001453687-26-000064", "filed": "2026-03-09", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001453687.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001453687.json" }, "ticker": "RNAC" }